Skip to main content

Table 1 Patient characteristics part I

From: Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy

Pat.No. Age * Type of recurrence** Years after primary disease Histology primary disease Histology recurrent disease Local therapy of primary disease
1 53.9 IBTR 3 lob-inv lob-inv BCS + 56 Gy
2 67.2 IBTR 3 duct-inv duct-inv BCS + 56 Gy
3 52.1 SBC. 4 duct-inv aden-cyst BCS + 62 Gy
4 65.8 SBC 9 lob-inv duct-inv BCS + 56 Gy
5 80.7 IBTR 11 lob-inv lob-inv BCS + 56 Gy
6 70.6 IBTR 4 duct-inv duct-inv BCS + 49 Gy
7 74.1 IBTR 9 lob-inv lob-inv BCS + 56 Gy
8 53.9 SBC 13 lob-inv duct-inv BCS + 56 Gy
9 48.3 IBTR 14 duct-inv duct-inv BCS + 50 Gy
10 75.8 IBTR 17 duct-inv duct-inv BCS + 56 Gy
11 78.0 IBIR 10 DCIS duct-inv BCS + 56 Gy
12 60.8 IBTR 14 muc-inv muc-inv BCS + 56 Gy
13 58.0 IBTR 7 duct-inv duct-inv BCS + 56 Gy
14 58.5 IR 10 DCIS duct-inv BCS + 56 Gy
15 86.9 IBTR 16 duct-inv duct-inv BCS + 56 Gy
16 56,8 BC after Hodgkin 5 nodular duct-inv Med 30 Gy
17 66.2 BC after Hodgkin 25 nodular duct-lob-inv Med 40 Gy
  1. * Age at time of IBTR, ** Different types of recurrences:
  2. IBTR = In-breast tumour recurrences (which have the same histology and localization)
  3. SBC = Secondary breast cancer (which show a different histology)
  4. IR = Invasive recurrences (after previous DCIS)
  5. BC after Hodgkin = invasive breast cancer after Hodgkin's disease.
  6. Histologies: Duct-inv = ductal-invasive, lob-inv = lobular-invasive, DCIS = Ductal carcinoma in situ, muc-inv = mucinous-invasive, nodular = nodular Hodgkin's disease, duct-lob-inv = mixed histology, partly ductal-invasive, partly lobular-invasive.
  7. Local therapy of primary disease: BCS = breast conserving surgery
  8. Med 30/40 Gy = the two patients with Hodgkin's disease were treated by involved field radiotherapy to the mediastinal lymph nodes with 30/40 Gy respectively.